0001437749-23-016002.txt : 20230526 0001437749-23-016002.hdr.sgml : 20230526 20230526171624 ACCESSION NUMBER: 0001437749-23-016002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230525 FILED AS OF DATE: 20230526 DATE AS OF CHANGE: 20230526 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Climaco John M CENTRAL INDEX KEY: 0001546797 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37758 FILM NUMBER: 23970300 MAIL ADDRESS: STREET 1: PO BOX 326 CITY: PARK CITY STATE: UT ZIP: 84060 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Moleculin Biotech, Inc. CENTRAL INDEX KEY: 0001659617 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474671999 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5300 MEMORIAL DRIVE STREET 2: SUITE 950 CITY: HOUSTON STATE: TX ZIP: 77007 BUSINESS PHONE: 713-300-5160 MAIL ADDRESS: STREET 1: 5300 MEMORIAL DRIVE STREET 2: SUITE 950 CITY: HOUSTON STATE: TX ZIP: 77007 4 1 rdgdoc.xml FORM 4 X0407 4 2023-05-25 0001659617 Moleculin Biotech, Inc. MBRX 0001546797 Climaco John M C/O MOLECULIN BIOTECH, INC. 5300 MEMORIAL DR., SUITE 950 HOUSTON TX 77007 1 0 Stock option (right to buy) 0.62 2023-05-25 4 A 0 15000 A 2033-05-25 Common Stock 15000 77501 D The options set forth in this table vest on the earlier of one year from the date of the Company's 2023 annual meeting of stockholders or on the next annual meeting of stockholders, subject to the grantee's continued service on the Company's Board of Directors on such vesting date. The options were issued in connection with the reporting person's Board of Director service to the Company. /s/ Jonathan Foster by Power of Attorney 2023-05-26